196 related articles for article (PubMed ID: 24032519)
1. Disrupted pulmonary artery cyclic guanosine monophosphate signaling in mice with hyperoxia-induced pulmonary hypertension.
Lee KJ; Berkelhamer SK; Kim GA; Taylor JM; O'Shea KM; Steinhorn RH; Farrow KN
Am J Respir Cell Mol Biol; 2014 Feb; 50(2):369-78. PubMed ID: 24032519
[TBL] [Abstract][Full Text] [Related]
2. Aberrant cGMP signaling persists during recovery in mice with oxygen-induced pulmonary hypertension.
Perez M; Lee KJ; Cardona HJ; Taylor JM; Robbins ME; Waypa GB; Berkelhamer SK; Farrow KN
PLoS One; 2017; 12(8):e0180957. PubMed ID: 28792962
[TBL] [Abstract][Full Text] [Related]
3. Right ventricular cyclic nucleotide signaling is decreased in hyperoxia-induced pulmonary hypertension in neonatal mice.
Heilman RP; Lagoski MB; Lee KJ; Taylor JM; Kim GA; Berkelhamer SK; Steinhorn RH; Farrow KN
Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1575-82. PubMed ID: 25862831
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury.
Ladha F; Bonnet S; Eaton F; Hashimoto K; Korbutt G; Thébaud B
Am J Respir Crit Care Med; 2005 Sep; 172(6):750-6. PubMed ID: 15947285
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury.
de Visser YP; Walther FJ; Laghmani el H; Boersma H; van der Laarse A; Wagenaar GT
Respir Res; 2009 Apr; 10(1):30. PubMed ID: 19402887
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent effects of glucocorticoids on pulmonary vascular development in a murine model of hyperoxic lung injury.
Perez M; Wisniewska K; Lee KJ; Cardona HJ; Taylor JM; Farrow KN
Pediatr Res; 2016 May; 79(5):759-65. PubMed ID: 26756781
[TBL] [Abstract][Full Text] [Related]
7. The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats.
Lang M; Kojonazarov B; Tian X; Kalymbetov A; Weissmann N; Grimminger F; Kretschmer A; Stasch JP; Seeger W; Ghofrani HA; Schermuly RT
PLoS One; 2012; 7(8):e43433. PubMed ID: 22912874
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil in hypoxic pulmonary hypertension potentiates a compensatory up-regulation of NO-cGMP signaling.
Kirsch M; Kemp-Harper B; Weissmann N; Grimminger F; Schmidt HH
FASEB J; 2008 Jan; 22(1):30-40. PubMed ID: 17679609
[TBL] [Abstract][Full Text] [Related]
9. Brief hyperoxia increases mitochondrial oxidation and increases phosphodiesterase 5 activity in fetal pulmonary artery smooth muscle cells.
Farrow KN; Lee KJ; Perez M; Schriewer JM; Wedgwood S; Lakshminrusimha S; Smith CL; Steinhorn RH; Schumacker PT
Antioxid Redox Signal; 2012 Aug; 17(3):460-70. PubMed ID: 22229392
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil inhibits hypoxia-induced transient receptor potential canonical protein expression in pulmonary arterial smooth muscle via cGMP-PKG-PPARγ axis.
Wang J; Yang K; Xu L; Zhang Y; Lai N; Jiang H; Zhang Y; Zhong N; Ran P; Lu W
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):231-40. PubMed ID: 23526219
[TBL] [Abstract][Full Text] [Related]
11. Sildenafil alleviates bronchopulmonary dysplasia in neonatal rats by activating the hypoxia-inducible factor signaling pathway.
Park HS; Park JW; Kim HJ; Choi CW; Lee HJ; Kim BI; Chun YS
Am J Respir Cell Mol Biol; 2013 Jan; 48(1):105-13. PubMed ID: 23065129
[TBL] [Abstract][Full Text] [Related]
12. SOD2 activity is not impacted by hyperoxia in murine neonatal pulmonary artery smooth muscle cells and mice.
Gupta A; Perez M; Lee KJ; Taylor JM; Farrow KN
Int J Mol Sci; 2015 Mar; 16(3):6373-90. PubMed ID: 25809610
[TBL] [Abstract][Full Text] [Related]
13. Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice.
Pradhan K; Sydykov A; Tian X; Mamazhakypov A; Neupane B; Luitel H; Weissmann N; Seeger W; Grimminger F; Kretschmer A; Stasch JP; Ghofrani HA; Schermuly RT
Int J Cardiol; 2016 Aug; 216():85-91. PubMed ID: 27140341
[TBL] [Abstract][Full Text] [Related]
14. Decreased Cyclic Guanosine Monophosphate-Protein Kinase G Signaling Impairs Angiogenesis in a Lamb Model of Persistent Pulmonary Hypertension of the Newborn.
Sharma M; Rana U; Joshi C; Michalkiewicz T; Afolayan A; Parchur A; Joshi A; Teng RJ; Konduri GG
Am J Respir Cell Mol Biol; 2021 Nov; 65(5):555-567. PubMed ID: 34185619
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic assessment of pulmonary hypertension using high-resolution echocardiography is feasible in neonatal mice with experimental bronchopulmonary dysplasia and pulmonary hypertension: a step toward preventing chronic obstructive pulmonary disease.
Reynolds CL; Zhang S; Shrestha AK; Barrios R; Shivanna B
Int J Chron Obstruct Pulmon Dis; 2016; 11():1597-605. PubMed ID: 27478373
[TBL] [Abstract][Full Text] [Related]
16. Antenatal sildenafil treatment attenuates pulmonary hypertension in experimental congenital diaphragmatic hernia.
Luong C; Rey-Perra J; Vadivel A; Gilmour G; Sauve Y; Koonen D; Walker D; Todd KG; Gressens P; Kassiri Z; Nadeem K; Morgan B; Eaton F; Dyck JR; Archer SL; Thébaud B
Circulation; 2011 May; 123(19):2120-31. PubMed ID: 21537000
[TBL] [Abstract][Full Text] [Related]
17. Riociguat prevents hyperoxia-induced lung injury and pulmonary hypertension in neonatal rats without effects on long bone growth.
Donda K; Zambrano R; Moon Y; Percival J; Vaidya R; Dapaah-Siakwan F; Luo S; Duncan MR; Bao Y; Wang L; Qin L; Benny M; Young K; Wu S
PLoS One; 2018; 13(7):e0199927. PubMed ID: 29990355
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats.
Wagenaar GT; Sengers RM; Laghmani el H; Chen X; Lindeboom MP; Roks AJ; Folkerts G; Walther FJ
Am J Physiol Lung Cell Mol Physiol; 2014 Aug; 307(3):L261-72. PubMed ID: 24951776
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats.
de Visser YP; Walther FJ; Laghmani el H; Steendijk P; Middeldorp M; van der Laarse A; Wagenaar GT
Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(1):L56-67. PubMed ID: 21949154
[TBL] [Abstract][Full Text] [Related]
20. The role of rhIGF-1/BP3 in the prevention of pulmonary hypertension in bronchopulmonary dysplasia and its underlying mechanism.
Qu S; Shan L; Chen X; Zhang Z; Wu Y; Chen Y; Zhuo F; Wang Y; Dong H
BMC Pulm Med; 2023 Jun; 23(1):209. PubMed ID: 37322452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
